Among the analysed tumours, nine (69.23%) displayed either no or extremely low cytoplasmic staining, while four tumours (30.77%) showed low cytoplasmic immunoreactivity (< 85% of tumour cells expressing SSTR2). This evidence concerns the gene SSTR2 and neoplasm.